These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy. Jomier F; Bousson V; Viala K; Péréon Y; Magot A; Cauquil C; Bouhour F; Vial C; Bedat-Millet AL; Taithe F; Bresch S; Siri A; Kubis N; Lozeron P Eur J Neurol; 2020 Jan; 27(1):181-187. PubMed ID: 31348848 [TBL] [Abstract][Full Text] [Related]
26. Elevated leukocyte count in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy. Lucke IM; Peric S; van Lieverloo GGA; Wieske L; Verhamme C; van Schaik IN; Basta I; Eftimov F J Peripher Nerv Syst; 2018 Mar; 23(1):49-54. PubMed ID: 29341326 [TBL] [Abstract][Full Text] [Related]
27. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy. Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568 [TBL] [Abstract][Full Text] [Related]
28. Expression Analysis of Protein Inhibitor of Activated STAT in Inflammatory Demyelinating Polyradiculoneuropathy. Ghafouri-Fard S; Hussen BM; Nicknafs F; Nazer N; Sayad A; Taheri M Front Immunol; 2021; 12():659038. PubMed ID: 34054823 [TBL] [Abstract][Full Text] [Related]
29. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies. Reynolds J; Sachs G; Stavros K R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997 [TBL] [Abstract][Full Text] [Related]
30. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary? Wadwekar V; Kalita J; Misra UK Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647 [TBL] [Abstract][Full Text] [Related]
31. Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy. Bjelica B; Basta I; Bozovic I; Kacar A; Nikolic A; Dominovic-Kovacevic A; Vukojevic Z; Martic V; Stojanov A; Djordjevic G; Petrovic M; Stojanovic M; Peric S J Peripher Nerv Syst; 2018 Sep; 23(3):178-182. PubMed ID: 29999199 [TBL] [Abstract][Full Text] [Related]
32. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness. Mygland A; Monstad P Arch Neurol; 2003 Feb; 60(2):260-4. PubMed ID: 12580713 [TBL] [Abstract][Full Text] [Related]
37. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. Nobile-Orazio E J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201 [TBL] [Abstract][Full Text] [Related]
38. Disease activity in chronic inflammatory demyelinating polyneuropathy: A comparative study of clinical and skin biopsy markers. Acarli ANÖ; Ünverengil G; Şirin NG; Çakar A; Durmuş H; Parman Y Muscle Nerve; 2022 Dec; 66(6):736-743. PubMed ID: 36151750 [TBL] [Abstract][Full Text] [Related]
39. Clinical factors, diagnostic delay, and residual deficits in chronic inflammatory demyelinating polyradiculoneuropathy. Bunschoten C; Blomkwist-Markens PH; Horemans A; van Doorn PA; Jacobs BC J Peripher Nerv Syst; 2019 Sep; 24(3):253-259. PubMed ID: 31410938 [TBL] [Abstract][Full Text] [Related]
40. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]